Physician profile
Tony Joseph Masri
NPI 1548458466
$327,096.34
in general payments reported to CMS, 2019-2025
12 companies · $160K in 2025
The $160K reported for 2025 was more than what 99% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $82.75 · 2021: $227 · 2022: $591 · 2023: $55K · 2024: $110K · 2025: $160K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $324K · Travel and Lodging: $1,251 · Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $323,927.41 |
| Travel and Lodging | $1,250.56 |
| Food and Beverage | $894.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $325,193.62 | 2023-2025 | Lifevest |
| Jazz Pharmaceuticals INC. | $704.03 | 2019-2025 | |
| Antares Pharma, INC. | $394.10 | 2020-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $310.51 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $122.73 | 2023 | Sunosi |
| Philips North America LLC | $110.58 | 2019-2022 | |
| Itamar Medical INC | $66.34 | 2023 | Watchpatone |
| Harmony Biosciences LLC | $56.29 | 2020-2021 | |
| Eisai INC. | $51.74 | 2021 | |
| Resmed Corp | $40.37 | 2021 | |
| Zoll Medical Corporation | $29.83 | 2024 | Defibrillator |
| Arbor Pharmaceuticals, INC. | $16.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tony Masri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.